Oral microbiome link to neurodegeneration in glaucoma

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Astafurov, Konstantin ^a   Elhawy, Eman ^a   Ren, Lizhen ^a   Dong, Cecilia Q ^a   Igboin, Christina ^b   Hyman, Leslie ^c,d   Griffen, Ann ^b   Mittag, Thomas ^e   Danias, John ^a,d  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^d State University of New York (SUNY) at Binghamton   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; NALOXONE; TOLL LIKE RECEPTOR 4; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; CELL ACTIVATION; CELL COUNT; CELL LOSS; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; GENE EXPRESSION; GLAUCOMA; MALE; MICROGLIA; MOLECULAR PATHOLOGY; MOUSE; MOUTH FLORA; NERVE DEGENERATION; NONHUMAN; OPTIC NERVE; OUTCOME ASSESSMENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; RETINA NERVE CELL; SIGNAL TRANSDUCTION; UPREGULATION; AFRICAN AMERICAN; ANIMAL; BRAIN; C57BL MOUSE; COMPLICATION; DBA MOUSE; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; INTRAOCULAR PRESSURE; METABOLISM; MICROBIOLOGY; MICROFLORA; MOUTH; OPTIC DISK; PATHOLOGY; PATHOPHYSIOLOGY;

AFRICAN AMERICANS; ANIMALS; BRAIN; COMPLEMENT SYSTEM PROTEINS; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LIPOPOLYSACCHARIDES; MALE; MICE, INBRED C57BL; MICE, INBRED DBA; MICROBIOTA; MICROGLIA; MOUTH; NERVE DEGENERATION; OPTIC DISK; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84929509617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104416     Document Type: Article

References (49)

1. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90: 262-267.
2. Gordon MO, Torri V, Miglior S, Beiser JA, Floriani I, et al. (2007) Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology 114: 10-19.
3. Fingert JH (2011) Primary open-angle glaucoma genes. Eye (Lond) 25: 587-595.
4. Stasi K, Nagel D, Yang X, Wang RF, Ren L, et al. (2006) Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci 47: 1024-1029. (Pubitemid 46768335)
5. Bosco A, Steele MR, Vetter ML (2011) Early microglia activation in a mouse model of chronic glaucoma. J Comp Neurol 519: 599-620.
6. Ebneter A, Casson RJ, Wood JP, Chidlow G (2010) Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci 51: 6448-6460.
7. Wyss-Coray T, Rogers J (2011) Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2: a006346.
8. Hirsch EC, Vyas S, Hunot S (2009) Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord 18 Suppl 1: S210-212.
9. Dunn N, Mullee M, Perry VH, Holmes C (2005) Association between dementia and infectious disease: evidence from a case-control study. Alzheimer Dis Assoc Disord 19: 91-94. (Pubitemid 41073086)
10. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, et al. (2003) Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74: 788-789. (Pubitemid 36628295)
11. Pott Godoy MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ (2008) Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131: 1880-1894. (Pubitemid 351957456)
12. Yokochi T, Inoue Y, Yokoo J, Kimura Y, Kato N (1989) Retention of bacterial lipopolysaccharide at the site of subcutaneous injection. Infect Immun 57: 1786-1791. (Pubitemid 19140144)
13. Danias J, Lee KC, Zamora MF, Chen B, Shen F, et al. (2003) Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci 44: 5151-5162. (Pubitemid 37475383)
14. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, et al. (1998) Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 39: 951-962. (Pubitemid 28196680)
15. Libby RT, Anderson MG, Pang IH, Robinson ZH, Savinova OV, et al. (2005) Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci 22: 637-648. (Pubitemid 43237759)
16. Anderson MG, Smith RS, Hawes NL, Zabaleta A, Chang B, et al. (2002) Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet 30: 81-85.
17. Rosenbaum JT, Rosenzweig HL, Smith JR, Martin TM, Planck SR (2008) Uveitis secondary to bacterial products. Ophthalmic Res 40: 165-168. (Pubitemid 351562897)
18. Chen H, Wei X, Cho KS, Chen G, Sappington R, et al. (2011) Optic neuropathy due to microbead-induced elevated intraocular pressure in the mouse. Invest Ophthalmol Vis Sci 52: 36-44.
19. Amor S, Puentes F, Baker D, van der Valk P (2010) Inflammation in neurodegenerative diseases. Immunology 129: 154-169.
20. Luo C, Yang X, Kain AD, Powell DW, Kuehn MH, et al. (2010) Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling. Invest Ophthalmol Vis Sci 51: 5697-5707.
21. Takano Y, Shi D, Shimizu A, Funayama T, Mashima Y, et al. (2012) Association of Toll-like receptor 4 gene polymorphisms in Japanese subjects with primary open-angle, normal-tension, and exfoliation glaucoma. Am J Ophthalmol 154: 825-832 e821.
22. Howell GR, Macalinao DG, Sousa GL, Walden M, Soto I, et al. (2011) Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest 121: 1429-1444.
23. Hutchinson MR, Coats BD, Lewis SS, Zhang Y, Sprunger DB, et al. (2008) Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav Immun 22: 1178-1189.
24. Ni YQ, Xu GZ, Hu WZ, Shi L, Qin YW, et al. (2008) Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation. Invest Ophthalmol Vis Sci 49: 2589-2598.
25. Rasmussen CA, Gabelt BT, Kaufman PL (2007) Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine. Trans Am Ophthalmol Soc 105: 225-238; discussion 238-229.
26. Akiyama H, McGeer PL (1990) Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 30: 81-93. (Pubitemid 20324759)
27. Hofman P, Hoyng P, vanderWerf F, Vrensen GF, Schlingemann RO (2001) Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head. Invest Ophthalmol Vis Sci 42: 895-901. (Pubitemid 32289782)
28. Howell GR, Soto I, Zhu X, Ryan M, Macalinao DG, et al. (2012) Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma. J Clin Invest 122: 1246-1261.
29. Morrison HW, Filosa JA (2013) A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion. J Neuroinflammation 10: 4.
30. McCusker RH, Kelley KW (2013) Immune-neural connections: how the immune system's response to infectious agents influences behavior. J Exp Biol 216: 84-98.
31. Zoellner H (2011) Dental infection and vascular disease. Semin Thromb Hemost 37: 181-192.
32. Saito T, Shimazaki Y (2007) Metabolic disorders related to obesity and periodontal disease. Periodontol 2000 43: 254-266.
33. Krabbe KS, Reichenberg A, Yirmiya R, Smed A, Pedersen BK, et al. (2005) Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun 19: 453-460. (Pubitemid 41074784)
34. Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, et al. (2004) Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Arch Neurol 61: 668-672. (Pubitemid 38637682)
35. Schram MT, Euser SM, de Craen AJ, Witteman JC, Frolich M, et al. (2007) Systemic markers of inflammation and cognitive decline in old age. J Am Geriatr Soc 55: 708-716. (Pubitemid 46668977)
36. Kim JM, Kim SH, Park KH, Han SY, Shim HS (2011) Investigation of the association between Helicobacter pylori infection and normal tension glaucoma. Invest Ophthalmol Vis Sci 52: 665-668.
37. Kountouras J, Mylopoulos N, Konstas AG, Zavos C, Chatzopoulos D, et al. (2003) Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol 241: 884-890. (Pubitemid 37527047)
38. Zullo A, Ridola L, Hassan C, Bruzzese V, Papini F, et al. (2012) Glaucoma and Helicobacter pylori: eyes wide shut? Dig Liver Dis 44: 627-628.
39. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, et al. (2008) Association of Toll-like receptor 4 gene polymorphisms with normal tension glaucoma. Invest Ophthalmol Vis Sci 49: 4453-4457.
40. Hutchinson MR, Zhang Y, Brown K, Coats BD, Shridhar M, et al. (2008) Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). Eur J Neurosci 28: 20-29.
41. Martin WR (1967) Opioid antagonists. Pharmacol Rev 19: 463-521.
42. Husain S, Abdul Y, Crosson CE (2012) Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Invest Ophthalmol Vis Sci 53: 4289-4298.
43. Ishida N, Ishihara Y, Ishida K, Tada H, Kato Y, et al. (2013) Periodontitis induced by bacterial infection exacerbates features of Alzheimer's disease in transgenic mice. Alzheimer's & Dementia 9S: 851.
44. Danias J, Kontiola AI, Filippopoulos T, Mittag T (2003) Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci 44: 1138-1141. (Pubitemid 36297832)
45. Nissirios N, Goldblum D, Rohrer K, Mittag T, Danias J (2007) Noninvasive determination of intraocular pressure (IOP) in nonsedated mice of 5 different inbred strains. J Glaucoma 16: 57-61. (Pubitemid 46114775)
46. Pang IH, Johnson EC, Jia L, Cepurna WO, Shepard AR, et al. (2005) Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage. Invest Ophthalmol Vis Sci 46: 1313-1321. (Pubitemid 41685871)
47. Marina N, Bull ND, Martin KR (2010) A semiautomated targeted sampling method to assess optic nerve axonal loss in a rat model of glaucoma. Nat Protoc 5: 1642-1651.
48. Gross EL, Leys EJ, Gasparovich SR, Firestone ND, Schwartzbaum JA, et al. (2010) Bacterial 16S sequence analysis of severe caries in young permanent teeth. J Clin Microbiol 48: 4121-4128.
49. Lyons SR, Griffen AL, Leys EJ (2000) Quantitative real-time PCR for Porphyromonas gingivalis and total bacteria. J Clin Microbiol 38: 2362-2365. (Pubitemid 30414365)